Nijah Dorvilier, DNP Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 2500 Belle Chasse Hwy, Terrytown, LA 70056 Phone: 504-392-3131 |
Dr. Leslie C Linder, DNP Registered Nurse - Wound Care Medicare: Not Enrolled in Medicare Practice Location: 821 Mystic Ave, Terrytown, LA 70056 Phone: 504-762-5252 Fax: 504-762-5678 |
Miss Dasha Jacqueline Arnold, CRNA Registered Nurse Medicare: Accepting Medicare Assignments Practice Location: 2500 Belle Chasse Hwy, Terrytown, LA 70056 Phone: 504-391-5157 |
Mason William Ducote, NNP-BC Registered Nurse - Neonatal Intensive Care Medicare: Medicare Enrolled Practice Location: 2500 Belle Chasse Hwy, Terrytown, LA 70056 Phone: 504-392-3131 |
Heidi Winborne, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 116 Terry Pkwy Ste E, Terrytown, LA 70056 Phone: 985-227-8644 |
Gail Parry, Registered Nurse - Wound Care Medicare: Not Enrolled in Medicare Practice Location: 2500 Belle Chasse Hwy, Terrytown, LA 70056 Phone: 504-391-5559 |
Mrs. Amanda Rivero Smith, MSN-HCSM, RN, NPD-BC Registered Nurse - Administrator Medicare: Not Enrolled in Medicare Practice Location: 2500 Belle Chasse Hwy, Terrytown, LA 70056 Phone: 504-391-5138 |
Rhonda Mcclain, Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 214 Apollo St, Terrytown, LA 70056 Phone: 504-338-5010 |
Jacqueline Parks Warren, RN, MSN, CMSRN Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 657 Wright Ave, Terrytown, LA 70056 Phone: 504-812-1344 |
News Archive
CVS Caremark is sponsoring research to investigate patient adherence to prescription drug therapies and identify ways to increase adherence. Working with researchers from Harvard and Brigham and Women's Hospital, the company expects knowledge gained from the research will help health professionals better understand patient behavior and lead to developing programs that health care providers and pharmacies can use to improve medication adherence and ultimately help improve patient care and medical outcomes by avoiding costly hospital treatment.
Merck & Co., Inc. today announced that the Food and Drug Administration (FDA) has approved changes to the prescribing information for PROSCARĀ® (finasteride) based on a landmark National Institutes of Health (NIH) study.
Impax Laboratories, Inc. today announced that its generics division, Global Pharmaceuticals, commenced shipment of authorized generic Zomig (zolmitriptan) tablets and orally disintegrating tablets, 2.5 mg and 5 mg, in the U.S., as part of a Distribution, License, Development and Supply Agreement with AstraZeneca UK Limited.
FDA review periods are lengthening for IVD tests that utilize molecular biomarkers, and at a faster rate than for IVDs overall, one of the key findings in a new report published this month by Amplion Research.
› Verified 3 days ago